{ "as_of": "2026-11-01", "track": "cell-therapy", "programs": [ { "id": "cell-asset-99ac80d0fee99b7e", "asset_id": "AbClon Inc.::AT101 (nespecabtagene autoleucel)", "company_id": "co-be32a718a56d2959", "company": "AbClon Inc.", "company_zh": null, "country": "Korea", "country_basis": "South Korea", "code": "AT101", "asset": "AT101 (nespecabtagene autoleucel)", "mechanism": "CAR-T", "stage": "Phase 2 interim results (May 2025 milestone)", "stage_detail": "Phase 2 interim results (May 2025 milestone)", "stage_detail_zh": "Phase 2 interim results (May 2025 milestone)", "indication": null, "partner": null, "terms": null, "sources": [ { "url": "https://www.abclon.com/en/history.html", "source_date": "2025-05", "accessed_on": "2026-11-01", "title": "Abclon - History KOR ENG KO / EN About us Overview CAR-T GMP History Collaboration Technology CAR-T platform NEST platform AffiMab platform Pipeline AT101 AT501 AC101 AM201 AM105 AM109 Antibody Servic" } ], "source_date": "2025-05" }, { "id": "cell-PL001", "asset_id": "PELL BMT::PL001", "company_id": "co-ad3d55aa7384365c", "company": "PELL BMT", "company_zh": "沛爾生醫-創", "country": "Taiwan", "country_basis": "Company domicile; trial region retained separately", "trial_region": "台灣", "code": "PL001", "asset": "PL001", "mechanism": "CD19 CAR-T", "stage": "Phase 1 / Phase 2; active not recruiting", "stage_detail": "Phase 1 / Phase 2; active not recruiting", "stage_detail_zh": "第I/II期；已停止招募但仍在研究中", "indication": "Diffuse Large B Cell Lymphoma; Primary Mediastinal Large B Cell Lymphoma; Large B-cell Lymphoma; Follicular Lymphoma Grade 3A; Follicular Lymphoma Grade 3B", "indication_zh": "復發或難治性B細胞淋巴瘤", "partner": null, "terms": null, "sources": [ { "url": "https://clinicaltrials.gov/api/v2/studies/NCT05326243", "source_date": "2026-10-09", "accessed_on": "2026-11-01", "title": "Existing Taiwan cell-therapy dataset source", "verification": "UPSTREAM_DATED_RECORD" } ], "source_date": "2026-10-09" }, { "id": "cell-PL002", "asset_id": "PELL BMT::PL002", "company_id": "co-ad3d55aa7384365c", "company": "PELL BMT", "company_zh": "沛爾生醫-創", "country": "Taiwan", "country_basis": "Company domicile; trial region retained separately", "trial_region": "地區未揭露", "code": "PL002", "asset": "PL002", "mechanism": "間皮素多鏈CAR-T", "stage": "Preclinical", "stage_detail": "Preclinical", "stage_detail_zh": "臨床前", "indication": null, "indication_zh": "卵巢癌", "partner": null, "terms": null, "sources": [ { "url": "https://www.pellbmt.com/upload/investor/files/20260528081035.PDF", "source_date": "2026-05-27", "accessed_on": "2026-11-01", "title": "Existing Taiwan cell-therapy dataset source", "verification": "UPSTREAM_DATED_RECORD" } ], "source_date": "2026-05-27" }, { "id": "cell-PL003", "asset_id": "PELL BMT::PL003", "company_id": "co-ad3d55aa7384365c", "company": "PELL BMT", "company_zh": "沛爾生醫-創", "country": "Taiwan", "country_basis": "Company domicile; trial region retained separately", "trial_region": "地區未揭露", "code": "PL003", "asset": "PL003", "mechanism": "BCMA CAR-T", "stage": "Preclinical", "stage_detail": "Preclinical", "stage_detail_zh": "臨床前", "indication": null, "indication_zh": "多發性骨髓瘤", "partner": null, "terms": null, "sources": [ { "url": "https://www.pellbmt.com/upload/investor/files/20260528081035.PDF", "source_date": "2026-05-27", "accessed_on": "2026-11-01", "title": "Existing Taiwan cell-therapy dataset source", "verification": "UPSTREAM_DATED_RECORD" } ], "source_date": "2026-05-27" }, { "id": "cell-PL004", "asset_id": "PELL BMT::PL004", "company_id": "co-ad3d55aa7384365c", "company": "PELL BMT", "company_zh": "沛爾生醫-創", "country": "Taiwan", "country_basis": "Company domicile; trial region retained separately", "trial_region": "地區未揭露", "code": "PL004", "asset": "PL004", "mechanism": "in vivo CAR-T", "stage": "Preclinical", "stage_detail": "Preclinical", "stage_detail_zh": "早期研發／臨床前", "indication": null, "indication_zh": "適應症未揭露", "partner": null, "terms": null, "sources": [ { "url": "https://www.pellbmt.com/upload/investor/files/20260528081035.PDF", "source_date": "2026-05-27", "accessed_on": "2026-11-01", "title": "Existing Taiwan cell-therapy dataset source", "verification": "UPSTREAM_DATED_RECORD" } ], "source_date": "2026-05-27" }, { "id": "cell-UWFAP", "asset_id": "UWELL::UWFAP", "company_id": "tw-7902", "company": "UWELL", "company_zh": "宇越生醫", "country": "Taiwan", "country_basis": "Company domicile; trial region retained separately", "trial_region": "地區未揭露", "code": "UWFAP", "asset": "UWFAP", "mechanism": "FAP CAR-T", "stage": "Preclinical", "stage_detail": "Preclinical", "stage_detail_zh": "臨床前研究（法說圖示）", "indication": null, "indication_zh": "肝硬化", "partner": null, "terms": null, "sources": [ { "url": "https://www.uwell.com.tw/_i/assets/upload/files/%E6%B3%95%E8%AA%AA%E6%9C%83%E7%B0%A1%E5%A0%B1.pdf", "source_date": "2026-01-15", "accessed_on": "2026-11-01", "title": "Existing Taiwan cell-therapy dataset source", "verification": "UPSTREAM_DATED_RECORD" } ], "source_date": "2026-01-15" }, { "id": "cell-UWN2D", "asset_id": "UWELL::UWN2D", "company_id": "tw-7902", "company": "UWELL", "company_zh": "宇越生醫", "country": "Taiwan", "country_basis": "Company domicile; trial region retained separately", "trial_region": "地區未揭露", "code": "UWN2D", "asset": "UWN2D", "mechanism": "NKG2D CAR-T", "stage": "Preclinical", "stage_detail": "Preclinical", "stage_detail_zh": "臨床前研究（法說圖示）", "indication": null, "indication_zh": "膠質母細胞瘤、胰臟癌", "partner": null, "terms": null, "sources": [ { "url": "https://www.uwell.com.tw/_i/assets/upload/files/%E6%B3%95%E8%AA%AA%E6%9C%83%E7%B0%A1%E5%A0%B1.pdf", "source_date": "2026-01-15", "accessed_on": "2026-11-01", "title": "Existing Taiwan cell-therapy dataset source", "verification": "UPSTREAM_DATED_RECORD" } ], "source_date": "2026-01-15" } ], "deals": [] }